Fund profile by ISIN IE00BYXG2H39
iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
Research iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) by ISIN IE00BYXG2H39: TER 0.35%, domicile Ireland, accumulating, and 1-year price performance +47.9%.
ISINIE00BYXG2H39
TER0.35%
DomicileIreland
Distribution policyAccumulating
IndexNASDAQ Biotechnology NET Index
Fund size1.2B
Holdings251
1-year price performance+47.9%
Exchange listings and tradability
| Ticker | Exchange | Currency | Country | Avg daily turnover | Avg daily shares |
|---|---|---|---|---|---|
| 2B70.DE | XETRADefault at German brokers | EUR | Ireland | €1.9M | 220,485 |
| BTEC.L | LSE | USD | Ireland | €1.0M | 112,504 |
| BTEC.SW | SW | USD | Ireland | €643K | 71,760 |
| BTEK.L | LSE | GBP | Ireland | €312K | 34,867 |
Avg daily turnover is the 90-day average, converted to euros so venues in different currencies can be compared; avg daily shares is the same window in units. The most traded listing is shown first. This fund trades on a German exchange. As of 2026-10-12.
Largest holdings
The 10 largest holdings make up 46.01% of the fund, which holds 251 positions in total. As of 2026-10-08.
| Holding | Symbol | Weight |
|---|---|---|
| GILEAD SCIENCES | GILD | 8.41% |
| AMGEN INC | AMGN | 7.91% |
| VERTEX PHARMACEUTICALS | VRTX | 7.72% |
| MODERNA | MRNA | 5.38% |
| REGENERON PHARMACEUTICALS | REGN | 5.12% |
| REVOLUTION MEDICINES | RVMD | 2.76% |
| ILLUMINA INC | ILMN | 2.73% |
| BIOGEN | BIIB | 2.21% |
| ALNYLAM PHARMACEUTICALS | ALNY | 2.06% |
| ROYALTY PHARMA PLC CLASS A | RPRX | 1.71% |
Performance is the historical price return of the representative listing. Distributions are excluded and past performance is not a forecast.